PT  - JOURNAL ARTICLE
AU  - Stoliaroff-Pepin, Anna
AU  - Peine, Caroline
AU  - Herath, Tim
AU  - Lachmann, Johannes
AU  - Perriat, Delphine
AU  - Dörre, Achim
AU  - Nitsche, Andreas
AU  - Michel, Janine
AU  - Grossegesse, Marica
AU  - Hofmann, Natalie
AU  - Rinner, Thomas
AU  - Kohl, Claudia
AU  - Brinkmann, Annika
AU  - Meyer, Tanja
AU  - Dorner, Brigitte G.
AU  - Stern, Daniel
AU  - Treindl, Fridolin
AU  - Hein, Sascha
AU  - Werel, Laura
AU  - Hildt, Eberhard
AU  - Gläser, Sven
AU  - Schühlen, Helmut
AU  - Isner, Caroline
AU  - Peric, Alexander
AU  - Ghouzi, Ammar
AU  - Reichardt, Annette
AU  - Janneck, Matthias
AU  - Lock, Guntram
AU  - Schaade, Lars
AU  - Wichmann, Ole
AU  - Harder, Thomas
TI  - Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022
AID  - 10.1101/2022.06.28.22276303
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.06.28.22276303
4099  - http://medrxiv.org/content/early/2022/06/29/2022.06.28.22276303.short
4100  - http://medrxiv.org/content/early/2022/06/29/2022.06.28.22276303.full
AB  - We included 852 patients in a prospectively recruiting multicenter matched case-control study in Germany to assess vaccine effectiveness (VE) in preventing COVID-19-associated hospitalization (Delta-variant dominance). Two-dose VE was 89% (95%CI 84-93%) overall, 79% in patients with >2 comorbidities and 77% in adults aged 60-75 years. A third dose increased VE to >93% in all patient-subgroups.Competing Interest StatementS. G. received payment/honoraria from Astra Zeneca, Boehringer Ingelheim, Roche Pharma and Berlin Chemie, this had no influence on this work; all other authors reported no conflicts of interest.Funding StatementThe study is funded by the German Federal Ministry of HealthAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethikkommission der Charite, Chariteplatz 1, 10117 Berlin gave ethical approval for this work (EA1/063/23)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors